Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation

Haematologica. 2005 Feb;90(2):278-9.

Abstract

We report the successful use of bortezomib to treat a patient with multiple myeloma (MM) who had extramedullary relapse (paraspinal and thoracic masses and multiple cranial nerve palsy) after autologous and non-myeloablative allogeneic hematopoietic stem cell transplantation (HSCT).

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Biopsy
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Female
  • Hematopoietic Stem Cell Transplantation / methods
  • Humans
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / therapy*
  • Protease Inhibitors / pharmacology
  • Pyrazines / therapeutic use*
  • Recurrence
  • Tomography, X-Ray Computed
  • Transplantation, Autologous / methods*
  • Transplantation, Homologous / methods*

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Protease Inhibitors
  • Pyrazines
  • Bortezomib